Skip to Main Content

Rigel Pharmaceuticals

Rigel Pharmaceuticals develops innovative therapies for hematologic disorders and cancers, including TAVALISSE®, REZLIDHIA®, and GAVRETO®.

Site Profile
Security Setup
BMissing 1 of 7 security checks
  • No Referrer-Policy

Passing

SSL certificate · HTTPS enforced · HSTS · X-Frame-Options · X-Content-Type · TLS 1.3

Not Set

Content-Security-Policy · Permissions-Policy

Last scanned

Rigel-Pharmaceuticals Homepage 1440px